New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases

• Main Authors: Wujun Chen (Author), Yingjie Zhong (Author), Nuan Feng (Author), Zhu Guo (Author), Shuai Wang (Author), Dongming Xing (Author)
• Format: Book
• Published: BMC, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Age-related cardiovascular disease is the leading cause of death in elderly populations. Coxibs, including celecoxib, valdecoxib, etoricoxib, parecoxib, lumiracoxib, and rofecoxib, are selective cyclooxygenase-2 (COX-2) inhibitors used to treat osteoarthritis and rheumatoid arthritis. Howev...